Denhardt, Chambers: "Overcoming obstacles to metastasis--defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells." in: Journal of cellular biochemistry, Vol. 56, Issue 1, pp. 48-51, 1995 (PubMed).
Denhardt, Lopez, Rollo et al.: "Osteopontin-induced modifications of cellular functions." in: Annals of the New York Academy of Sciences, Vol. 760, pp. 127-42, 1995 (PubMed).
Weber, Cantor: "The immunology of Eta-1/osteopontin." in: Cytokine & growth factor reviews, Vol. 7, Issue 3, pp. 241-8, 1997 (PubMed).
Uede, Katagiri, Iizuka et al.: "Osteopontin, a coordinator of host defense system: a cytokine or an extracellular adhesive protein?" in: Microbiology and immunology, Vol. 41, Issue 9, pp. 641-8, 1997 (PubMed).
Liaw, Birk, Ballas et al.: "Altered wound healing in mice lacking a functional osteopontin gene (spp1)." in: The Journal of clinical investigation, Vol. 101, Issue 7, pp. 1468-78, 1998 (PubMed).
Rittling, Matsumoto, McKee et al.: "Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro." in: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, Vol. 13, Issue 7, pp. 1101-11, 1998 (PubMed).
Crawford, Matrisian, Liaw: "Distinct roles of osteopontin in host defense activity and tumor survival during squamous cell carcinoma progression in vivo." in: Cancer research, Vol. 58, Issue 22, pp. 5206-15, 1998 (PubMed).
Yoshitake, Rittling, Denhardt et al.: "Osteopontin-deficient mice are resistant to ovariectomy-induced bone resorption." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, Issue 14, pp. 8156-60, 1999 (PubMed).
Noiri, Dickman, Miller et al.: "Reduced tolerance to acute renal ischemia in mice with a targeted disruption of the osteopontin gene." in: Kidney international, Vol. 56, Issue 1, pp. 74-82, 1999 (PubMed).
Nau, Liaw, Chupp et al.: "Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin." in: Infection and immunity, Vol. 67, Issue 8, pp. 4223-30, 1999 (PubMed).
Ophascharoensuk, Giachelli, Gordon et al.: "Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis." in: Kidney international, Vol. 56, Issue 2, pp. 571-80, 1999 (PubMed).
Ashkar, Weber, Panoutsakopoulou et al.: "Eta-1 (osteopontin): an early component of type-1 (cell-mediated) immunity." in: Science (New York, N.Y.), Vol. 287, Issue 5454, pp. 860-4, 2000 (PubMed).
McCawley, Matrisian: "Matrix metalloproteinases: multifunctional contributors to tumor progression." in: Molecular medicine today, Vol. 6, Issue 4, pp. 149-56, 2000 (PubMed).
Agnihotri, Crawford, Haro et al.: "Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin)." in: The Journal of biological chemistry, Vol. 276, Issue 30, pp. 28261-7, 2001 (PubMed).
Shin, Ahn, Kim et al.: "Temporal expression of osteopontin and CD44 in rat brains with experimental cryolesions." in: Brain research, Vol. 1041, Issue 1, pp. 95-101, 2005 (PubMed).
Kim, Shin: "Immunohistochemical study of osteopontin in boar testis." in: Journal of veterinary science, Vol. 8, Issue 2, pp. 107-10, 2007 (PubMed).
Iwanaga, Ueno, Ueki et al.: "The expression of osteopontin is increased in vessels with blood-brain barrier impairment." in: Neuropathology and applied neurobiology, Vol. 34, Issue 2, pp. 145-54, 2008 (PubMed).